Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 20.66B 3.06B 2.65B 2.49B 2.27B 4.26B 292B 4.33B 29.25B 11.43B 146B 11.5B 11.25B 488B P/E 2026 *
13.9x
P/E 2027 * 12.1x
Enterprise Value 17.14B 2.54B 2.2B 2.06B 1.88B 3.54B 242B 3.59B 24.27B 9.49B 121B 9.54B 9.34B 405B EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.5x
Free-Float
34.77%
Yield 2026 *
4.97%
Yield 2027 * 5.47%
1 day-3.82%
1 week-2.42%
Current month-3.77%
1 month+2.78%
3 months-3.51%
6 months-6.45%
Current year+2.95%
1 week 17.41
Extreme 17.41
19.99
1 month 17.41
Extreme 17.41
19.99
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
29.78
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 2019-02-27
Director of Finance/CFO 44 2018-05-09
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 63 2016-08-07
Chairman 59 2013-07-15
Chairman 48 2015-05-27
Change 5-day change 1-year change 3-year change Capi.($)
-3.82%-2.42%+4.13%-36.51% 3.18B
-1.47%-0.87%-25.98%-23.73% 16.03B
-2.21%-7.38%-32.83%-37.38% 7.47B
-1.60%+3.48%-25.33%-13.36% 6.31B
-2.48%+7.09%-0.08%-25.39% 4.43B
0.00%+0.73%-21.30%-37.50% 3.33B
-0.18%-1.39%-41.24%-23.83% 3.11B
+0.06%-1.21%-14.55%+2.16% 2.63B
-2.23%-4.74%+70.56% - 2.5B
-1.60%-1.63%-3.02%+17.71% 1.56B
Average -1.55%+0.74%-8.97%-19.76% 5.06B
Weighted average by Cap. -1.62%+1.11%-17.30%-23.69%

Financials

2026 *2027 *
Net sales 29.91B 4.43B 3.84B 3.6B 3.28B 6.17B 423B 6.27B 42.34B 16.55B 212B 16.65B 16.29B 706B 33.03B 4.9B 4.24B 3.98B 3.63B 6.82B 467B 6.92B 46.77B 18.28B 234B 18.39B 17.99B 780B
Net income 1.48B 220M 191M 179M 163M 306M 21B 311M 2.1B 822M 10.51B 827M 809M 35.06B 1.71B 254M 220M 206M 188M 354M 24.25B 359M 2.43B 949M 12.14B 955M 934M 40.49B
Net Debt -3.52B -522M -452M -424M -386M -726M -49.77B -738M -4.98B -1.95B -24.92B -1.96B -1.92B -83.1B -4.01B -595M -515M -483M -440M -828M -56.71B -840M -5.68B -2.22B -28.4B -2.23B -2.18B -94.69B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
26-08-11 CN¥18.14 -3.82% 12,579,930
26-08-11 CN¥18.86 +3.46% 19,793,347
26-08-10 CN¥18.23 +4.11% 11,895,319
26-08-07 CN¥17.51 -2.23% 12,008,564
26-08-06 CN¥17.91 -1.92% 8,642,848
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.14CNY
Average target price
24.70CNY
Spread / Average Target
+36.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock